These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 10695989
1. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung. Maser E, Stinner B, Atalla A. Cancer Lett; 2000 Feb 01; 148(2):135-44. PubMed ID: 10695989 [Abstract] [Full Text] [Related]
2. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung. Atalla A, Maser E. Toxicology; 1999 Nov 29; 139(1-2):155-66. PubMed ID: 10614696 [Abstract] [Full Text] [Related]
3. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung. Finckh C, Atalla A, Nagel G, Stinner B, Maser E. Chem Biol Interact; 2001 Jan 30; 130-132(1-3):761-73. PubMed ID: 11306092 [Abstract] [Full Text] [Related]
4. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta. Atalla A, Maser E. Chem Biol Interact; 2001 Jan 30; 130-132(1-3):737-48. PubMed ID: 11306090 [Abstract] [Full Text] [Related]
8. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways. Prokopczyk B, Trushin N, Leszczynska J, Waggoner SE, El-Bayoumy K. Carcinogenesis; 2001 Jan 30; 22(1):107-14. PubMed ID: 11159748 [Abstract] [Full Text] [Related]
11. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen. Maser E, Friebertshäuser J, Völker B. Chem Biol Interact; 2003 Feb 01; 143-144():435-48. PubMed ID: 12604230 [Abstract] [Full Text] [Related]
15. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Smith TJ, Liao AM, Liu Y, Jones AB, Anderson LM, Yang CS. Carcinogenesis; 1997 Aug 01; 18(8):1577-84. PubMed ID: 9276633 [Abstract] [Full Text] [Related]
18. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney. Richter E, Friesenegger S, Engl J, Tricker AR. Toxicology; 2000 Apr 03; 144(1-3):83-91. PubMed ID: 10781874 [Abstract] [Full Text] [Related]
19. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells. Smith GB, Castonguay A, Donnelly PJ, Reid KR, Petsikas D, Massey TE. Carcinogenesis; 1999 Sep 03; 20(9):1809-18. PubMed ID: 10469628 [Abstract] [Full Text] [Related]
20. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes. Collazo NR, Sultatos LG. Biochem Pharmacol; 1995 Nov 27; 50(11):1933-41. PubMed ID: 8615875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]